Table GPS-14. Lifetime prevalence of drug use among the 15–24 age group in nationwide surveys among the general population

Country Geographical area		Year	Reference	Age range youngest adults	Sample size (15–24)	Cannabis (%)	Cocaine (%) (1)	Amphetamines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium
Vlaanderen (Brussels excluded)		1994	(1)
French Community		1996–97	(2)	18–24		16.1
French Community		1998–99	(3)	18–24		31.8
French Community		2000	(4)	18–24		39.8
National		2001	(5)	15–24	1152	21.0		3.9
National		2004	(6)	15–24		22.3
Bulgaria
National		2005	(1)	18–24	173	13.5	3.8	4.4	3.8	2.7
Czech Republic
National		2002	(1)	18–24	389	45.5		5.6	13.2	5.3
National		2004	(2)	18–24	586	43.9	2.1	4.9	18.7	3.7
Denmark
National		1990	(1)
National		1994	(2)
National		2000	(3)	16–24	1754	40.9	4.7	10.9	4.1	1.6
National		2005	(4)	16–24	1434	44.2	8.0	11.2	5.5	1.8
Germany
East Germany		1990	(1)
Western Germany		1990	(2)
Old and new Länder		1995	(3)	18–24		23.6	4.3	5.9	5.8
Old and new Länder		1997	(4)	18–24		21.5	2.1	2.5	4.9
National		2000	(5)	18–24	963	36.5	3.8	4.6	5.2	3.0
National		2003	(6)	18–24	1891	43.0	4.7	6.0	6.3	3.3
National		2006	(7)	18–24	1868	39.0	4.0	5.1	5.3	2.1
Estonia
National		1998	(1)	18–24		12.0	3.0	6.0	3.0	2.0
National		2003	(2)	15–24	329
Ireland
National		1998	(1)
National		1998	(2)	18–24		33.4
National		2000	(3)
National		2002–03	(4)	15–24		22.8	5.1	4.4	7.7	3.9
National		2006–07	(5)	15–24		24.8	7.0	3.2	6.5	1.0
Greece
Athens		1993	(1)
National (except Aegean and Ionian Islands)		1998	(2)	15–24	1373	16.6	1.7	0.7	0.8
National (except Aegean and Ionian Islands)		2004	(3)	15–24	1 785	9.0	0.6	0.2	0.4	0.5
Spain
National		1995	(1)
National		1997	(2)	15–24		5.6	1.4	3.8	5.7
National		1999	(3)	15–24		27.4	4.2	3.1	5.1
National		2001	(4)	15–24	3 368	35.0	6.7	4.5	8.0
National		2003	(5)	15–24	2327	38.0	7.7	3.8	8.5
National		2005–06	(6)	15–24	8188	38.9	8.7	4.9	6.9
France
National		1992	(1)
Metropolitan France		1995	(2)	18–24		30.1	0.3	1.7
National		1999	(3)	15–24		32.6	1.4	0.0	1.7	1.4
National		2000	(4)	15–24		38.0	1.6	1.1	2.1	2.3
Metropolitan France		2002	(5)	15–24	345	42.5	1.1	0.0	2.0	0.6
National		2005	(6)	15–24	4662	42.0	2.5	0.8	3.0	0.8
Italy
National		2001	(1)	15–24		22.6	2.3	0.7	1.5	0.0
National		2003	(2)	15–24	2112	27.3	5.2	1.5	2.6	3.0
National		2005	(3)	15–24	9006	32.6	5.7	1.7	2.5	3.5
Cyprus
National		2006	(1)	15–24	969	6.9	1.4	0.9	2.1	0.9
Latvia
National		2003	(1)	15–24		22.9	1.4	6.0	6.2	2.8
Lithuania
National		2004	(1)	15–24	923	15.7	0.7	2.6	2.6	0.7
Luxembourg
National		1998	(1)	15–24		16.1	0.5		2.3	1.8
Hungary
National		2001	(1)	15–24	308	19.0	1.9	5.0	6.0	6.0
National		2003	(2)	18–24	943	25.3	1.4	5.9	7.9	4.2
Malta
National		2001	(1)	18–24	287	4.9	1.1	1.1	1.7	1.6
Netherlands
National		1997–98	(1)	15–24		28.8	3.0	3.6	5.1	1.4
National		2001	(2)	15–24		32.2	3.1	6.1	9.2
National		2005	(3)	15–24		28.3	2.8	2.0	5.1	0.7
Austria
National		2004	(1)	15–24	959	29.7	2.9	3.7	5.2	1.8
Poland
National		2002	(1)	16–24		18.6	1.8	5.2	2.2	3.5
National		2006	(2)	15–24	1135	17.3	1.1	4.8	2.3	1.7
Portugal
National		2001	(1)	15–24	3099	12.2	1.1	0.4	1.8	0.7
National		2007	(2)	15–24	2211	15.1	1.4	0.8	2.1	0.6
Romania
National		2004	(1)	15–24		2.7	0.4	0.3	0.8	0.0
Slovakia
National		1996	(1)	15–24	309	19.3	2.9	1.9
National		1998	(2)	15–24	290	17.8	2.1	2.3	5.4
National		2000	(3)	15–24	297	22.1	2.2	1.4	5.6
National		2002	(4)	15–24	301	30.1	1.0	1.7	4.1
National		2004	(5)	15–24	307	29.6	1.0	1.3	7.8
National		2006	(6)	15–24	287	31.3	2.5	3.6	9.9
Finland
National		1992	(1)
National		1996	(2)
National		1998	(3)
National		2000	(4)	15–24		16.0	1.3	1.7	1.3	1.5
National		2002	(5)	15–24	614	25.2	1.6	4.3	3.9	1.8
National		2004	(6)	15–24	494	21.2	2.2	3.7	3.3	1.3
National		2006	(7)	15–24	654	19.0	1.3	3.9	3.3	1.0
Sweden
National		1994	(1)	16–24	146	2.8	0.0	0.0	0.0	0.6
National		1996	(2)	16–24	228	5.9	0.7	2.2	0.4	0.0
National		1998	(3)	16–24	244	9.6	0.8	2.0	1.2
National		2000	(4)	16–24		12.3	0.0	0.6	1.2	0.0
National		2004	(5)	16–24	1171	19.1
National		2005	(6)	16–24	4502	15.7
National		2006	(7)	16–24	7014	15.4
United Kingdom
England and Wales		1994	(1)	16–24	1442	36.5	3.0	15.7	8.1	11.7
England and Wales		1996	(2)	16–24	1475	39.6	4.7	18.8	11.7	13.1
England and Wales		1998	(3)	16–24	1295	45.4	7.1	21.5	10.8	12.3
England and Wales		2000	(4)	16–24	1517	46.2	10.7	21.2	11.7	11.4
England and Wales		2001–02	(5)	16–24	4057	44.2	8.5	15.9	12.0	6.8
England and Wales		2002–03	(6)	16–24	4292	43.6	9.6	15.3	12.5	6.1
England and Wales		2003–04	(7)	16–24	5429	42.2	10.0	13.1	11.3	4.8
England and Wales		2004–05	(8)	16–24	6287	41.1	9.3	11.6	10.8	3.5
England and Wales		2005–06	(9)	16–24	5892	40.1	10.8	11.3	10.4	3.7
England and Wales		2006–07	(10)	16–24	5749	39.5	11.2	11.2	10.3	3.2
Northern Ireland		2002–03	(11)	15–24		24.0	2.6	6.5	10.2	5.9
Northern Ireland		2005	(12)	16–24		28.9	6.3	8.6	10.7	1.3
Scotland		2003	(13)	16–24	619	37.7	10.8	13.0	14.3	6.1
Scotland		2004	(14)	16–24	330	33.9	5.6	10.3	7.0	3.8
Scotland		2006	(15)	16–24	426	48.9	15.6	15.6	14.8	5.0
United Kingdom		2004	(16)			40.4	9.0	12.3	11.0	4.5
Norway
National		1999	(1)	15–24		21.8	3.7	6.2	3.4
National		2004	(2)	15–24	645	23.4	3.4	5.3	3.4	0.8

Notes:

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs. 

 (3) For Spain: ecstasy and other designer drugs. 

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions. 

 For methods of each survey presented in this table, see Table GPS-1 part (ii).  

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 See Table GPS-0. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)